HOME >> BIOLOGY >> NEWS
OSA symptoms more common among African-American women than Caucasians

WESTCHESTER, Ill. In a study that examined the relationship between race, menopausal status and symptoms of obstructive sleep apnea (OSA), middle-aged African-American women were found to be more likely to experience OSA symptoms than their Caucasian counterparts, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Elizabeth Beothy, of the University of Pennsylvania, who authored the study, administered a questionnaire to 269 subjects, with an average age of 48, and 49.4 percent of which were African-American. Further, 37.5 percent of women were pre-menopausal, 43 percent in the menopausal transition and 19.5 percent post-menopausal.

The mean apnea score among African-American women was nearly double that of Caucasian women. Menopausal status was not a significant predictor of OSA symptoms. Race remained a significant predictor of OSA symptoms after adjustment for current body mass index (BMI), BMI change over time and menopausal status.

"Although menopausal status did not predict OSA symptoms, OSA symptoms on our cohort of menopausal women increased with higher BMI and larger BMI increases over time," said Beothy, who added that studies to document whether OSA is more common among African-American women than Caucasian women should be performed to further investigate these findings.

OSA affects an estimated 15 million to 20 million Americans, as well as millions more who remain undiagnosed and untreated.

Scientific evidence shows that CPAP is the best treatment for sleep apnea. CPAP provides a steady stream of pressurized air to patients through a mask that they wear during sleep. This airflow keeps the airway open, preventing the pauses in breathing that characterize OSA and restoring normal oxygen levels.


'"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
11-Jun-2007


Page: 1

Related biology news :

1. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
2. MIT researchers reverse symptoms in mice of leading inherited cause of mental retardation
3. Latest data shows MabThera provides significant, sustained relief from symptoms of RA
4. Gene malfunctions cause schizophrenia, depression symptoms in mice
5. Switching genes to overdrive improves muscular dystrophy symptoms in mice
6. Reversal of symptoms in an autism spectrum disorder
7. Malaria drug may treat metabolic syndromes many symptoms
8. Brain protein improves stroke symptoms in rats, even when injected after 3 days
9. Rush and UCSF found gene therapy appeared to reduce symptoms of Parkinsons by 40 percent
10. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
11. Researchers reverse Parkinsons symptoms in animal models

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology:
Cached News: